[1]王 乾,杨浩宇,贾宇衡,等.国家易短缺药品清单纳入品种分析及思考[J].卫生经济研究,2023,40(10):57-60.
　WANG Qian,YANG Haoyu,JIA Yuheng,et al.Analysis and Thoughts on the Varieties included in National Shortage Drug List[J].Journal Press of Health Economics Research,2023,40(10):57-60.
点击复制

国家易短缺药品清单纳入品种分析及思考
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
40
期数:
2023年10期
页码:
57-60
栏目:
药械管理
出版日期:
2023-09-28

文章信息/Info

Title:
Analysis and Thoughts on the Varieties included in National Shortage Drug List
作者:
王 乾1; 杨浩宇1; 贾宇衡1; 洪立信1; 田 侃2
1.南京中医药大学卫生经济管理学院，江苏 南京 210023
2.南京中医药大学养老服务与管理学院，江苏 南京 210023
Author(s):
WANG Qian;  YANG Haoyu;  JIA Yuheng;  HONG Lixin;  TIAN Kan
School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing Jiangsu 210023, China
关键词:
易短缺药品; 药品供应保障政策; 临床必需; 短缺药品清单
Keywords:
drugs in short supply;  drug supply guarantee policy;  clinical essentials;  list of shortage drugs
分类号:
R95
文献标志码:
A
摘要:
目的：分析国家易短缺药品清单纳入品种的特点，为完善易短缺药品供应保障政策提供参考。方法：对易短缺药品清单纳入药品的属性分类和主要特点进行梳理与分析。结果：易短缺药品清单共纳入了57个药品，涉及4个剂型，心血管系统用药最多（14个，占24.56%）；57个药品全部纳入医保目录，51个药品纳入基本药物目录，部分品种生产企业较少、市场供应短缺。结论：加强部门政策联动，动态调整易短缺药品清单目录；加强易短缺药品储备管理，完善监测预警机制；实施分类采购政策，落实停产备案制度，保障易短缺药品生产供应。
Abstract:
Objective To explore the characteristics of the varieties included in National Shortage Drug List, and to provide reference for improving the policy of ensuring the supply of drugs in short supply. Methods The attribute classification and main characteristics of drugs included in National Shortage Drug List were sorted and analyzed. Results The list included a total of 57 drugs, involving 4 dosage forms. The cardiovascular system had the most drugs, with 14 drugs accounting for 24.56%. All 57 drugs were included in the medical insurance catalog, and 51 drugs were included in the essential drug catalog. Some varieties were still in short supply in the market due to the lack of manufacturers. Conclusion In order to ensure the production and supply of drugs in short supply, it is necessary to strengthen departmental policy linkage and dynamically adjust the drug list, strengthen the management of drug reserves and improve the monitoring and warning mechanism; implement classified procurement policies and implement a filing system for stop production.

参考文献/References:

[1] 张伶俐，易秋莎.让临床患儿有药可用[J].中国卫生，2022（6）：86-87.
[2] 朱雅萌，傅鸿鹏.我国短缺药品现状分析与思考[J].卫生经济研究，2021，38（6）：59-62.
[3] 蒋丰，田侃.我国《临床急需境外新药名单》纳入品种及优化策略研究[J].中国药房，2023，34（1）：7-11.
[4] 李英楠.辽宁省短缺药品监测预警现状[J].中国药物经济学，2020，15（11）：88-91.

更新日期/Last Update: 2023-09-28